login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
INMED PHARMACEUTICALS INC (INM) Stock News
USA
- NASDAQ:INM -
CA4576377002
-
Common Stock
2.29
USD
-0.07 (-2.97%)
Last: 9/19/2025, 8:19:36 PM
2.36
USD
+0.07 (+3.06%)
After Hours:
9/19/2025, 8:19:36 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
INM Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Virtual Investor Conferences
- Mentions:
KLYG
UEEC
PETV
DRMA
...
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
4 days ago - By: Virtual Investor Conferences
InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025
4 days ago - By: Virtual Investor Conferences
- Mentions:
UEEC
KLYG
PETV
DRMA
...
Life Science Virtual Investor Forum Agenda Announced for September 18th
a year ago - By: Invezz
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Fiscal 2024 Financial Results, Provides Business Update
a year ago - By: Invezz
CBDNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) BayMedica Poised as Rare Cannabinoids Drive Market Growth
3 months ago - By: Benzinga
- Mentions:
CGTX
Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data
a year ago - By: Invezz
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Three U.S. Patent Issuances
a year ago - By: Invezz
BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Exciting INM-901 Data Providing ‘Attractive Therapeutic Approach’ in Alzheimer’s Treatment
3 months ago - By: Benzinga
Why InMed's Alzheimer's Drug Candidate Is Fueling Sudden Stock Surge
a year ago - By: Invezz
BioMedNewsBreaks — InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089 Showing Great Promise in Treating AMD
8 months ago - By: Stocktwits
Nano-Cap InMed Ignites Retail Frenzy As Stock Soars After Alzheimer's Drug Trial Shows Promise
a year ago - By: Invezz
InMed Pharmaceuticals Demonstrates INM-901 as an Oral Formulation Targeting Alzheimer’s Disease
a year ago - By: InvestorPlace
- Mentions:
SPCE
HSDT
PIII
SBFM
...
7 F-Rated Growth Stocks to Avoid Right Now: June 2024
Please enable JavaScript to continue using this application.